Regeneron Pharmaceuticals

• 11/13/2024

  Market Movers: 6 Key Stocks to Watch This Week

• 11/8/2024

  “Unlock Intellia Therapeutics’ 354% Upside Potential: A Gene-Editing Gem?”

• 9/29/2024

  **Regeneron: A Long-Term Defensive Play**

• 9/25/2024

  **EYLEA Patent Dispute: Impact on Regeneron Investors**